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Background
Left ventricular assist devices (LVAD) have become an
established mode of treatment in bridging patients with
advanced heart failure to cardiac transplantation. In cer-
tain groups of patients LVADs have proven their effi-
cacy as a destination therapy. Increasing mismatch
between the expanding pool of heart failure patients and
decline in availability of donor organs raises an impor-
tant question of prioritizing patients on the waiting list.
Methods
This is a retrospective analysis of post-transplant results
of patients bridged with HeartMate II. Patients were
divided based on pre-transplant etiology into ischemic,
non-ischemic and congenital group. One-year post-trans-
plant survival was calculated using the Kaplan-Meier
method and Log-rank test was used for comparison.
Results
Between 2007 and 2013 60 patients were transplanted
from HeartMate II at our institution. There were no dif-
ferences in patients’ pre-transplant demographic and
clinical variables. Donor characteristics as well as
ischemic times were also comparable. Overall one-year
post-transplant survival was 90 ± 2%. Patient with non-
ischemic etiology had 97 ± 3% survival compared to 86
±7% in patients with ischemic and 67 ± 19% in patients
with congenital heart disease (p = 0.043).
Conclusion
Our data indicate that patients with congenital heart
disease bridged to transplantation with HeartMate II
have significantly reduced one-year post-transplant sur-
vival compared to patients with other cardiomyopathies.
In the era of the current donor shortage, there is an
increased pressure at judicious utilization of resources
and surgical outcomes are increasingly scrutinized.
Every effort should be made at identifying risk factors
for diminished post-transplant survival. We believe that
advancements in LVADs technical design associated
with improved survival and quality of life make new
generation devices a viable alternative as a definitive
treatment option for a very high risk transplant patients.
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